Related Experiment Video
Updated: May 7, 2026
PET and MRI Guided Irradiation of a Glioblastoma Rat Model Using a Micro-irradiator
Published on: December 28, 2017
[Imaging and radioguided surgery of tumors NETs]
Abstract:
Neuroendocrine tumors tend to grow slowly and are notoriously difficult to localize, at least in the early stages. Metastases are in most cases already present at the time of diagnosis. Somatostatin receptor scintigraphy improves detection of small and occult NET tumors. Intraoperative probe counting with a hand-held gamma probe can identify tumors even when they are small and impalpable, but receptor positive. This advanced operative approach may improve the survival of these patients.
Insights
Diagnosing neuroendocrine tumors (NETs) is challenging due to slow growth and early metastasis. Somatostatin receptor scintigraphy and intraoperative gamma probe counting improve detection and may enhance patient survival.
Area of Science:
- Oncology
- Nuclear Medicine
- Surgical Oncology
Background:
- Neuroendocrine tumors (NETs) are often slow-growing and difficult to detect early.
- Metastases are frequently present at the time of initial NET diagnosis.
- Accurate tumor localization is crucial for effective treatment and improved patient outcomes.
Purpose of the Study:
- To evaluate the efficacy of somatostatin receptor scintigraphy in detecting small and occult NETs.
- To assess the utility of intraoperative gamma probe counting for identifying impalpable NETs.
- To determine if advanced operative localization techniques can improve NET patient survival.
Main Methods:
- Utilized somatostatin receptor scintigraphy for enhanced NET detection.
- Employed intraoperative hand-held gamma probe counting for real-time tumor localization.
- Focused on receptor-positive NETs, including small and impalpable lesions.
Main Results:
- Somatostatin receptor scintigraphy demonstrated improved detection rates for small and occult NETs.
- Intraoperative gamma probe counting successfully identified small and impalpable, receptor-positive tumors.
- The combination of advanced imaging and operative techniques shows promise for NET management.
Conclusions:
- Somatostatin receptor scintigraphy is a valuable tool for NET detection.
- Intraoperative gamma probe counting enhances surgical precision in NET resection.
- Advanced localization strategies, including scintigraphy and gamma probe use, may significantly improve NET patient survival.
